Dr Reddys Laboratories (RDY) Free Cash Flow (2009)
Dr Reddys Laboratories (RDY) posted quarterly Free Cash Flow of $70.0 million for Q4 2009, down 38.05% on a QoQ basis from $113.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Free Cash Flow (2009) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Free Cash Flow for 1 consecutive years, with $70.0 million the latest figure, recorded in Q4 2009.
- Quarterly Free Cash Flow changed N/A year-over-year to $70.0 million in Q4 2009, while the trailing twelve-month figure through Sep 2010 was $70.0 million (down 70.45% YoY) and the FY2026 annual result came in at $358.0 million, up 60.54% from the prior year.
- Free Cash Flow retreated to $70.0 million in Q4 2009 per RDY's latest filing, from $113.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for RDY reached as high as $113.0 million in Q3 2009 and fell as low as $70.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 70.00 Mn |
| Dec 31, 2009 | 70.00 Mn |
| Sep 30, 2009 | 113.00 Mn |
| Sep 30, 2009 | 113.00 Mn |
| Jun 30, 2009 | 111.00 Mn |
| Jun 30, 2009 | 111.00 Mn |